Hospital Angeles Metropolitano; Room 220

Mexico City, Mexico CITY (federal District) 06760

0 studies enrolling now · 2 studies all time

What they study most

Gastric Cancer, Metastatic Breast Cancer

Studies at this site

• A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer — Completed
• A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer — Completed